5DX — Meta Health Cashflow Statement
0.000.00%
Last trade - 00:00- SG$5.28m
- SG$7.15m
- SG$1.36m
Annual cashflow statement for Meta Health, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 7.67 | -7.37 | -3.33 | -1.05 | -1.26 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -7.56 | 1.55 | -0.084 | 0.57 | 0.139 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.62 | 0.949 | -0.354 | -0.654 | 0.107 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.289 | -2.25 | -2.24 | -1.09 | -0.945 |
| Capital Expenditures | -0.315 | -0.494 | -0.414 | 0 | -0.004 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3.5 | -1.76 | 5.11 | -1.6 | -0.3 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 3.19 | -2.25 | 4.7 | -1.6 | -0.304 |
| Financing Cash Flow Items | -0.45 | -0.821 | -0.394 | -0.141 | -0.125 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.48 | -2.3 | -0.284 | -2.29 | 1.24 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.97 | -6.94 | 1.95 | -4.98 | 0.007 |